General Manager of Tikun Olam-Cannabit

Avinoam Sapir, General Manager of Tikun Olam-Cannbit, has a cumulative experience of two decades in the field of pharmaceuticals, in which he has held a number of positions in management, marketing, sales, and acquisitions, and mergers. He was previously the General Manager of SLE (Israel’s largest distribution company), CEO of Teva Israel, and founder and chairman of the Sanara Ventures Investment Fund (JV), and Manager of Africa and Middle East region for Global Teva.

Executive Vice President

Jonah Rosenblatt is a veteran wall street trader/investor and has assisted in the funding of startups for years raising an excess of $10 million. For 15 years Jonah struggled to keep his daughter alive while she was highly addicted to Opioids. He spent approx. ~$1 million in treatment attempts to save her life and none of them ended with the result he desired. It ended with Jonah witnessing the death of his child 6 and 1/2 years ago. He spent countless hours with Dr. Miller to fine tune the right treatment protocol and create the perfect antidote to the Opiodemic plague. OpioStop is Jonah’s kid.

Deputy General Manager for Business Development

Guy has extensive experience in creating international partnerships and managing technology projects in the world of health. He is a graduate of a course for naval officers (Major in the reserves), a Bachelor’s degree in Political Science and Business Administration in the framework of his military service, a second Bachelor’s degree in Plant Sciences and Biotechnology from the Hebrew University, and a Master’s degree from the Department of Molecular Genetics at the Weizmann Institute of Science.

CMO (Medical)

Dr. Peter Miller is Chief Medical Officer at OpioStop. He is the CEO and founder of MillerBioConnect in Boca Raton, FL. A pathology medical center that assists patients in Covid care and testing. Dr. Miller received his doctorate at the Sackler School of Medicine in Tel Aviv, Israel. He was the Medical Director for InnovaMed Labs and held CEO as well. The company specialized in transfusion medical centers in South Florida and provided low cost blood products to hospitals. Dr. Miller was additionally Medical Director for Mobile Apheresis Inc. They specialized in plasmapheresis, also known as therapeutic plasma exchange (TPE), a nonsurgical therapy that removes and replaces a patient's blood plasma. He has extensive business leadership experience as well as a chemistry background that is essential to OpioStop’s success.

Head Researcher

Lihi runs the company’s R&D department, which includes conducting clinical research, data collection and database management, analysis, and product development, with the aim of creating top-quality cannabis products, while building innovative and groundbreaking partnerships in this field. Lihi is studying for a Ph.D. in Epidemiology at the Clinical Research Center at Soroka Medical Center and at Ben Gurion University, under the tutorship of Prof. Victor Novack and Prof. Raphael Mechoulam, the father of research into medical cannabis.